View Older Stories View More Recent Stories

Nov 18, 2024 09:00AM Avenzo Therapeutics Provides Corporate Update and Announces Closing of Series A/A-1 Financing
Nov 18, 2024 06:40AM Tuya Inc. (TUYA) Announces Anchor Investment by 65 Equity Partners
Nov 18, 2024 06:30AM Tuya Announces Anchor Investment by 65 Equity Partners
Nov 14, 2024 02:00AM Emulate Energy and Smartcar Partner to Drive EV Utilization as Distributed Energy Resources
Nov 8, 2024 06:58PM Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Nov 7, 2024 09:11PM Form SC 13D/A CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
Nov 5, 2024 05:36PM Form 144 CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 8A L P
Nov 5, 2024 05:36PM Form 144 CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES VIII L P
Nov 1, 2024 04:10PM Form SC 13G/A Tuya Inc. Filed by: New Enterprise Associates 14, L.P.
Oct 29, 2024 08:00AM Pathos AI Closes $62M Oversubscribed Series C Round of Financing to Accelerate its Platform Approach to Drug Development
Oct 24, 2024 06:08AM US autonomous truck startup Outrider raises $62 million to scale up
Oct 24, 2024 06:00AM Outrider Closes $62 Million Series D Financing to Drive Growth of Yard Automation
Oct 21, 2024 08:55PM Form SC 13D/A Inventiva S.A. Filed by: New Enterprise Associates 17, L.P.
Oct 20, 2024 08:00AM Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+ Attendees to World's Premier Healthcare Transformation Event
Oct 17, 2024 09:00AM Stride Annual Open Enrollment Research Reveals 73% of ACA Buyers Will Not Compare Plans Heading into 2025, Despite Anticipated Premium Increases
Oct 16, 2024 06:38AM Inventiva SA (IVA) PT Lowered to $13 at H.C. Wainwright
Oct 14, 2024 02:30AM Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study
Oct 8, 2024 07:35PM Form SC 13D/A OnKure Therapeutics, Filed by: New Enterprise Associates 15, L.P.
Oct 8, 2024 09:27AM Astellas and AviadoBio Announce Exclusive Option and License Agreement for Gene Therapy AVB-101 Targeting Frontotemporal Dementia and Other Indications
Oct 1, 2024 07:30AM ReCode Announces Two Key Additions to Scientific Advisory Board
Sep 25, 2024 10:01AM Revelation Partners Deepens Healthcare Expertise with Two New Hires
Sep 25, 2024 09:00AM Stride Publishes Study Revealing Financial Challenges Faced by Millions of Independent Workers
Sep 24, 2024 09:00AM Lyft and Smartcar Partner to Tackle the Top Pain Point for EV Drivers — Range Anxiety
Sep 23, 2024 06:06PM Form SC 13D MBX Biosciences, Inc. Filed by: New Enterprise Associates 17, L.P.
Sep 19, 2024 11:15AM Functional Finance Secures $20M Series A Funding Led by Walkabout Ventures
Sep 17, 2024 08:13PM Form 4 MBX Biosciences, Inc. For: Sep 16 Filed by: New Enterprise Associates 17, L.P.
Sep 17, 2024 01:48PM Invenra Welcomes Three Industry Leaders to Its Board of Directors
Sep 17, 2024 08:05AM DeltaStream Raises $15M in Series A Funding to Deliver the Future of Real-Time Stream Processing in Cloud
Sep 13, 2024 08:04AM 'AI godmother' Fei-Fei Li raises $230 million to launch AI startup
Sep 10, 2024 10:00AM Habitat Health announces founding leadership team and more than $50 million in capital investments
Sep 10, 2024 09:00AM HEAVY.AI Accelerates Big Data Analytics with Vultr's High-Performance GPU Cloud Infrastructure
Sep 5, 2024 06:58AM On National Cellulite Day, New Omnibus Survey Results Reveal Cellulite Myths and Find Nearly 80% of Women with Cellulite on Their Buttocks and Thighs State Creams and Gadgets Don't Work Over the Long
Sep 3, 2024 08:31AM CVRx (CVRX) Appoints Kevin Ballinger and Mitch Hill to its Board
Sep 3, 2024 08:30AM CVRx Announces Appointment of Two New Board Members
Aug 28, 2024 08:00AM Orby and Databricks Partner to Revolutionize Generative AI Automation for the Enterprise
Aug 19, 2024 08:00AM Orby Expands Industry’s Leading Research, Machine Learning And Foundation Model Team
Aug 13, 2024 08:01AM Moximed Completes Closing of Series D Financing for $91 Million to Accelerate Commercialization of MISHA® Knee System, an Implantable Shock Absorber for Knee Osteoarthritis
Aug 12, 2024 07:47PM Form SC 13D/A Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
Aug 12, 2024 08:00AM MBX Biosciences Doses First Patient in Phase 2 Avail™ Trial of MBX 2109 for the Treatment of Hypoparathyroidism
Aug 8, 2024 04:05PM Aligos Therapeutics Strengthens Board with Two New Independent Directors
Aug 7, 2024 08:00AM Orby Launches ActIO the First Agentic AI Foundation Model to Set New Industry-Leading Performance Benchmarks
Aug 5, 2024 08:00AM MBX Biosciences Raises $63.5 Million in Series C Financing to Advance Precision Endocrine Peptide™ (PEP™) Platform
Jul 23, 2024 08:00AM Clio announces US $900M investment at US $3B valuation to transform the legal experience for all
Jul 23, 2024 07:30AM Brenig Therapeutics Announces $65 Million Series A Financing to Advance Leading Pre-Clinical Parkinson's Disease Pipeline
Jul 23, 2024 07:00AM Magenta Medical Closes $105M Financing Led by Novo Holdings
Jul 17, 2024 04:09PM Form 144 Tuya Inc./ADR Filed by: New Enterprise Associates 14, L.P.
Jul 9, 2024 07:15AM Hivebrite takes Community Engagement to the Next Level with the Acquisition of AI-powered Matching Engine Orbiit
Jul 1, 2024 07:00AM ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center
Jun 27, 2024 08:00AM Orby AI Raises $30 Million to Deliver the First Large Action Model for AI Automation Unlocking Unrivaled Enterprise Efficiencies
Jun 25, 2024 08:00AM MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer
View More Recent Stories View Older Stories